The IPO Buzz: Cancer-Focused Caris Life Sciences (CAI) Unveils $400 Million IPO
Caris Life Sciences, Inc. (CAI Proposed), a cancer-focused precision medicine pioneer, revealed its IPO terms – 23.53 million shares at a price range of $16.00 to $18.00 – to raise $400.0 million, if priced at the $17.00 mid-point of its range – in an S-1/A filing early today, Monday, June 9, 2025. At pricing, Caris […]
June 9, 2025 Read More